Application 214735
- Type
- ANDA
- Sponsor
- GRANULES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214735-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214735-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | AA | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | AA | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Major Pharmaceuticals | 6e5bfe6d-d321-4f0f-86e2-457d8fd10a6a | 2026-03-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| glycopyrrolate | GLYCOPYRROLATE | Bionpharma Inc. | 512d3f1e-c35c-87c2-e063-6394a90a8de0 | 2026-03-05 | Warnings, Adverse reactions | glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 5ed930b7-a36e-4bf8-b1d1-dad238d3dd18 | 2026-02-25 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 10ea264f-e157-4e13-9d79-b4228daf359d | 2026-02-17 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Florida Pharmaceutical Products, LLC | 2cda1ed5-10bb-4651-acbf-be44ad709665 | 2026-02-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycate | GLYCOPYRROLATE | Intra-Sana Laboratories | 830ba1be-bef3-417c-a915-964cc6005b92 | 2026-01-13 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | eaf38b98-006f-4f4e-bc1c-6fe381f44b36 | 2026-01-07 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | b96c54a1-b8a5-4132-ae6d-725e0e5b91f4 | 2026-01-07 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE | AJENAT PHARMACEUTICALS LLC | 7049feaf-004a-481f-b129-996b21c3170a | 2025-12-29 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Jvet Pharmaceuticals LLC | 4b335c67-4f8f-47e5-abfc-f8c2c15496d7 | 2025-12-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurolife Pharma LLC | 677f8495-a870-45b6-bb65-75b449f040ce | 2025-12-11 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 5773cf63-4006-4d8f-b53b-c84bcfe19e4a | 2025-12-10 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Rising Pharma Holdings, Inc. | 58c4cb1f-59b8-4be9-a222-2264ca077d93 | 2025-12-03 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 430635e8-7c9e-77f6-e063-6294a90a4c8a | 2025-11-07 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Accord Healthcare, Inc., | 871797f0-697a-4a29-a37b-d06219e8f266 | 2025-10-17 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3f2b4281-55f3-43e3-e063-6294a90a56ba | 2025-09-18 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | ProPharma Distribution | 3edcc39d-0e29-4585-e063-6394a90ad512 | 2025-09-15 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3edd6a26-dd0f-2411-e063-6394a90affa2 | 2025-09-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Alembic Pharmaceuticals Inc. | 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2025-08-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Precision Dose, Inc. | e58f860b-e955-4d71-a128-93bd3812b08d | 2025-08-08 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.